goetzpartners advised TUEV SUED in the acquisition of MSource Group
TÜV SÜD AG, through its subsidiary TÜV SÜD Life Science GmbH, acquired all shares of clinical research organisation Msource Group, headquartered in Kraainem, Belgium, for an undisclosed consideration.
goetzpartners Munich acted as the exclusive financial advisor to TÜV SÜD. We were responsible for the definition of the high-level strategy to expand into a new business segment, the identification of potential targets in the CRO sector and advised in all steps of the Msource acquisition process. (German language)